| Overview |
| bsm-62084r-fitc-100ul |
| Apolipoprotein CI/APOC1 Recombinant Antibody, FITC Conjugated |
| WB, FCM, IF(ICC) |
| Human |
| Specifications |
| FITC |
| Rabbit |
| KLH conjugated synthetic peptide derived from human Apolipoprotein C1 |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 341 |
| P02654 |
| Secreted |
| APO C1; Apo CI; APOC 1; ApoC I; APOC1; APOC1B; ApolipoproteinCI. |
| Inhibitor of lipoprotein binding to the low density lipoprotein (LDL) receptor, LDL receptor-related protein, and very low density lipoprotein (VLDL) receptor. |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IF(ICC) |
1:50-200 |
Powered by Bioz